Hjem › Pankreaskreft › California › Sacramento
Kliniske studier for Pankreaskreft i Sacramento, CA
12 studier for Pankreaskreft søker deltakere på steder i og rundt Sacramento (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
RekruttererFase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
- Kaiser Permanente-South Sacramento, Sacramento
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruttererFase 3
- University of California, Davis Comprehensive Cancer Center, Sacramento
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekruttererObservasjonsstudie
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
RekruttererFase 1/2
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruttererFase 3
- Sutter Medical Center Sacramento, Sacramento
Pancreatic Cancer Early Detection Consortium
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- UC Davis, Sacramento
TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
RekruttererFase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- University of California, Davis Comprehensive Cancer Center, Sacramento
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekruttererFase 3
- Mercy Cancer Center - Sacramento, Sacramento
- Sutter Medical Center Sacramento, Sacramento
- Sutter Davis Hospital, Davis · 14 mi unna
- og 1 flere
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekruttererFase 1
- University of California, Davis Comprehensive Cancer Center, Sacramento
Pankreaskreft-studier i andre byer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andre studier i Sacramento
- Ikke-småcellet lungekreft29 studier
- Lungekreft22 studier
- Brystkreft20 studier
- Prostatakreft19 studier
- Metastatisk kreft16 studier
- Akut myelogen leukemi12 studier
- Hjertesvikt12 studier
- Kreft (alle typer)11 studier
- Tykktarmskreft11 studier
- Blærekreft10 studier
- Kolorektal kreft10 studier
- Type 2-diabetes9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.